The invention describes the use of novel aminodextran compounds containing about 5-20% by weight amine groups to bind a plurality of monoclonal antibodies. The resulting antibody-aminodextran compounds may be used to induce the activation and proliferation of selected mammalian cells. Specific examples...http://www.google.fr/patents/US5527713?utm_source=gb-gplus-shareBrevet US5527713 - Anti-CD3 antibody-aminodextran conjugates for induction of T-cell activation and proliferation
Anti-CD3 antibody-aminodextran conjugates for induction of T-cell activation ...
